Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology
Saved in:
Main Authors: | Dillon Nussbaum, BS (Author), Chapman Wei, MD (Author), Haig Pakhchanian, BS (Author), Rahul Raiker, BS (Author), Ivan Z. Liu, BS (Author), Adam Friedman, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis"
by: Dillon Nussbaum, BS, et al.
Published: (2022) -
Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023) -
Pityriasis rosea during the COVID-19 pandemic: Further support for a viral etiology
by: Harrison Zhu, BSA, et al.
Published: (2022) -
Prevalence of pityriasis rosea in the United States: A cross-sectional study using the All of Us database
by: Tejas P. Joshi, BS, et al.
Published: (2022) -
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
by: Francesco Drago, MD, et al.
Published: (2022)